Depression in the elderly. Characteristics and clinical management.
Major depression and clinically significant depressive symptoms occur commonly in the community-dwelling, medically ill, and institutionalized elderly. Both major depression and depressive symptoms need thorough evaluation and treatment because of the significant morbidity and mortality associated with these syndromes. Depression may be difficult to diagnose, especially in the medically ill elderly, because of the masking of depressive symptoms by somatic complaints or the presumption that symptoms are attributable to concurrent medical illness. Therefore, the clinician must be alert to the possibility of depression in the elderly patient. Although no specific diagnostic test is available, rating scales can be useful in screening for depression in the elderly patient. It is necessary to rule out medical illness or medications as contributing factors to depression. Psychotherapy and psychopharmacology, alone or in combination, are effective treatments for most elderly patients with depression. ECT is a safe and effective treatment for major depression in this population. Depression in the elderly is potentially a chronic and relapsing illness with significant associated medical and social morbidity. Because of their frequent contact with the elderly, nurses play a particularly important role in the diagnosis and treatment of depression. They need to recognize typical and atypical symptoms of depression and must be familiar with the potential side effects of antidepressant treatment. Close monitoring for these potential side effects can minimize disability. By working as a team with physicians, psychologists, and others, nurses have a necessary role in the care of the elderly depressed patient.
Steiner
D
D
University of Virginia School of Medicine, Department of Behavioral Medicine and Psychiatry, Staunton.
Marcopulos
B
B
D000368:Aged; D000375:Aging / Q000523:psychology; D003863:Depression / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D006801:Humans; D015995:Prevalence; D011379:Prognosis; D011613:Psychotherapy; D011619:Psychotropic Drugs / Q000627:therapeutic use; D014481:United States / Q000453:epidemiology
D011619:Psychotropic Drugs